Gilead Sciences, Inc. (BIT:1GILD)

Gilead Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,926	9,991	6,085	5,412	5,338	5,997
Short-Term Investments	785	1,577	2,265	1,446	2,067	2,827
Cash & Short-Term Investments	8,711	11,568	8,350	6,858	7,405	8,824
Cash Growth	57.69%	38.54%	21.76%	-7.39%	-16.08%	-64.23%
Accounts Receivable	4,388	4,420	4,660	4,777	4,493	4,892
Receivables	4,388	4,420	4,660	4,777	4,493	4,892
Inventory	1,759	1,710	1,787	1,507	1,618	1,683
Prepaid Expenses	1,581	480	559	1,241	1,181	585
Other Current Assets	462	995	729	60	75	12
Total Current Assets	16,901	19,173	16,085	14,443	14,772	15,996
Property, Plant & Equipment	5,421	5,929	5,898	5,980	5,663	5,613
Long-Term Investments	684	327	1,819	2,611	2,844	3,820
Goodwill	8,314	8,314	8,314	8,314	8,332	8,108
Other Intangible Assets	19,355	19,948	26,454	28,894	33,455	33,126
Long-Term Deferred Tax Assets	2,572	-	-	-	-	-
Other Long-Term Assets	3,187	5,304	3,555	2,929	2,886	1,744
Total Assets	56,434	58,995	62,125	63,171	67,952	68,407
Accounts Payable	737	833	550	905	705	844
Accrued Expenses	4,185	5,120	5,003	4,497	6,996	6,390
Current Portion of Long-Term Debt	2,806	1,815	1,798	2,273	1,516	2,757
Current Portion of Leases	-	113	125	111	101	107
Current Income Taxes Payable	-	1,646	1,208	959	539	598
Other Current Liabilities	4,616	2,477	2,596	2,492	1,753	701
Total Current Liabilities	12,344	12,004	11,280	11,237	11,610	11,397
Long-Term Debt	22,146	24,896	23,189	22,957	25,179	28,645
Long-Term Leases	-	498	546	467	489	608
Long-Term Deferred Tax Liabilities	709	724	1,588	2,673	4,356	3,914
Other Long-Term Liabilities	2,157	1,627	2,773	4,628	5,254	5,622
Total Liabilities	37,356	39,749	39,376	41,962	46,888	50,186
Common Stock	1	1	1	1	1	1
Additional Paid-In Capital	8,138	7,700	6,500	5,550	4,661	3,880
Retained Earnings	10,931	11,497	16,304	15,687	16,324	14,381
Comprehensive Income & Other	92	132	28	2	83	-60
Total Common Equity	19,162	19,330	22,833	21,240	21,069	18,202
Minority Interest	-84	-84	-84	-31	-5	19
Shareholders' Equity	19,078	19,246	22,749	21,209	21,064	18,221
Total Liabilities & Equity	56,434	58,995	62,125	63,171	67,952	68,407
Total Debt	24,952	27,322	25,658	25,808	27,285	32,117
Net Cash (Debt)	-16,241	-15,754	-16,145	-17,705	-18,571	-22,791
Net Cash Per Share	-12.91	-12.55	-12.83	-14.03	-14.72	-18.05
Filing Date Shares Outstanding	1,244	1,245	1,246	1,247	1,254	1,257
Total Common Shares Outstanding	1,245	1,246	1,246	1,247	1,254	1,254
Working Capital	4,557	7,169	4,805	3,206	3,162	4,599
Book Value Per Share	15.39	15.51	18.33	17.03	16.80	14.52
Tangible Book Value	-8,507	-8,932	-11,935	-15,968	-20,718	-23,032
Tangible Book Value Per Share	-6.83	-7.17	-9.58	-12.81	-16.52	-18.37
Land	-	561	561	562	404	404
Buildings	-	4,540	4,328	4,390	3,794	3,678
Machinery	-	2,282	2,216	1,990	1,759	1,697
Construction In Progress	-	501	661	719	1,057	856

Source: S&P Global Market Intelligence. Standard template. Financial Sources.